HOME >> MEDICINE >> NEWS
Post-traumatic stress disorder increases in children with extended ICU stays after cardiac surgery

New York, NY April 7, 2004 A study published in the April issue of The Journal of Pediatrics shows that the occurrence of Post-traumatic Stress Disorder (PTSD) increases significantly in school-age children who experience extended stays in the Intensive Care Unit (ICU) following cardiac surgery.

The study, led by Dana Connolly, Ph.D., Assistant Professor of Pediatrics at New York University School of Medicine in collaboration with Michael Artman, M.D., Director of Pediatric Cardiology at New York University School of Medicine, is the first of its kind to examine the psychosocial responses of school-age children to cardiac surgery. Forty-three families participated in the study, which took place at New York University Medical Center and Children's Medical Center in Dallas. The children from five-to- twelve years of age underwent cardiac surgery for congenital heart defects. Each child was evaluated pre- and post-operatively for PTSD using tools that determine anxiety disorders, nonverbal reasoning, and temperament. None of the children showed signs of PTSD before surgery.

During the post-surgical assessment, researchers found that characteristics of PTSD increased in children who stayed in the ICU for more than 48 hours after surgery. After hospitalization, five (12%) of the children met diagnostic criteria for PTSD, and five (12%) exhibited some of the characteristics of PTSD, including disorganized behavior, nightmares, sleep disorders, and concentration problems. Children exhibiting signs of PTSD were referred to pediatric psychiatrists for further evaluation.

"It's important for parents to look for behavioral changes such as bed wetting, night screams, clinging, and concentration problems once the child comes home from surgery," says Dr. Connolly. Despite efforts to minimize the stress and emotional trauma that can be associated with heart surgery for children and their families, the study showed, fo
'"/>

Contact: Deborah Coble
deborah.coble@med.nyu.edu
212-404-3522
New York University Medical Center and School of Medicine
7-Apr-2004


Page: 1 2

Related medicine news :

1. Post-traumatic stress disorder found in mothers whose children receive a bone marrow transplant
2. Violence exposure and traumatic stress reactions can lead to poor health in children
3. Sex hormone metabolite reduces stress, anxiety in female rats
4. Sudden death from stress linked to wonky signals in the brain
5. Money issues leading cause of holiday stress for Americans
6. Job-stressed women more vulnerable than men to 9/11 trauma
7. Family therapy reduces stress symptoms in adolescent survivors of childhood cancer
8. PITT, OHSU: When early life stress occurs determines its impact later
9. Scientists reveal significant behavioral impacts of early life stress, study therapies
10. Wartime spitfire strain test monitors stress on key heart artery - aortic aneurysm
11. Women exposed to frustrating noise stress snack more afterwards

Post Your Comments:
(Date:4/22/2014)... percent of all lung cancers are small cell ... develop resistance to chemotherapy. However, researchers at Virginia ... insights into the mechanisms leading to this resistance ... Chemotherapies work primarily by mediating B-cell lymphoma 2 ... cell death. Depending on their function, this family ...
(Date:4/22/2014)... 2014Hemoglobin A1c is the standard measurement for assessing glycemic ... of A1c are typically measured every few months in ... model that accurately estimates A1c using self-monitored blood glucose ... Therapeutics ( DTT ), a peer-reviewed journal from ... free on the DTT website at ...
(Date:4/22/2014)... PHILADELPHIA (April 22, 2014) That person we all seem ... take action? Turns out he or she isn,t unable to ... A study of nearly ... about why neurotic people may avoid making decisions and moving ... if action is positive, favorable, good, they just don,t like ...
(Date:4/22/2014)... -- In parallel with modern man ( Homo sapiens ), ... we lived side by side, such as Neanderthals and the ... sapiens survived. What was it in our genetic makeup ... little is known about our unique genetic makeup as distinguished ... fact that we are the only species among them ,to ...
(Date:4/22/2014)... Disease (IBD), a group of chronic inflammatory disorders of ... affects over 1.4 million people in the U.S., and ... there is no cure. , Now, Cincinnati Cancer ... Susan Waltz, PhD, and scientists in her lab have ... genetic study to document the important function for the ...
Breaking Medicine News(10 mins):Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Neurotics don't just avoid action: They dislike it 2Health News:What gave us the advantage over extinct types of humans? 2Health News:Two genes linked to inflammatory bowel disease 2
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: